Page last updated: 2024-11-01

omeprazole and Cancer of Spleen

omeprazole has been researched along with Cancer of Spleen in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerosa, Y1
Bernard, B1
Lagneau, M1
You, K1
Hoang, C1
Brasseur, JL1
Opolon, P1
Valla, D1

Other Studies

1 other study available for omeprazole and Cancer of Spleen

ArticleYear
[Cystic lymphangioma of the duodenum revealed by digestive hemorrhage and associated with exudative enteropathy].
    Gastroenterologie clinique et biologique, 1993, Volume: 17, Issue:8-9

    Topics: Aged; Duodenal Neoplasms; Gastrointestinal Hemorrhage; Humans; Jejunal Neoplasms; Kidney Neoplasms;

1993